Other OTC - Delayed Quote USD

Selectis Health, Inc. (GBCS)

2.0000 0.0000 (0.00%)
As of April 24 at 10:16 AM EDT. Market Open.
Loading Chart for GBCS
DELL
  • Previous Close 2.0000
  • Open 2.0000
  • Bid 0.1200 x 5000
  • Ask 0.5000 x 5000
  • Day's Range 2.0000 - 2.0000
  • 52 Week Range 1.0500 - 6.2500
  • Volume 2,000
  • Avg. Volume 572
  • Market Cap (intraday) 6.134M
  • Beta (5Y Monthly) -0.35
  • PE Ratio (TTM) --
  • EPS (TTM) -1.3100
  • Earnings Date May 14, 2024 - May 20, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 20, 2015
  • 1y Target Est --

Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.

www.selectis.com

574

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GBCS

Performance Overview: GBCS

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GBCS
53.49%
S&P 500
4.96%

1-Year Return

GBCS
55.56%
S&P 500
21.01%

3-Year Return

GBCS
71.43%
S&P 500
19.77%

5-Year Return

GBCS
33.33%
S&P 500
71.03%

Compare To: GBCS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GBCS

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    6.13M

  • Enterprise Value

    42.98M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.22

  • Enterprise Value/EBITDA

    -328.08

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.80%

  • Return on Assets (ttm)

    -13.47%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    36.78M

  • Net Income Avi to Common (ttm)

    -4M

  • Diluted EPS (ttm)

    -1.3100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.48M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.45M

Company Insights: GBCS

People Also Watch